Abstract Details

Title Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed and Other Early Multiple Sclerosis Patients, and Patients Switching from Interferon or Glatiramer Acetate, in Routine Medical Practice: Interim Results from ESTEEM

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 367

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Kathryn Giles PRESENTER	Kathryn Giles has stock in Synderdisc. The institution of Kathryn Giles has received research support from Biogen.
Jerome Hanna	No disclosure on file
Fan Wu, PhD	No disclosure on file
Catherine Miller	Catherine Miller has received personal compensation for serving as an employee of Biogen. Catherine Miller has received stock or an ownership interest from Biogen.
Konstantin E. Balashov, MD, PhD, FAAN (Department of Neurology, BMC and BUSM)	Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Richard A. Macdonell, MD, FAAN (Austin Health)	Dr. Macdonell has nothing to disclose.
Joerg Windsheimer, MD	No disclosure on file
Nicholas J. Everage	No disclosure on file